摘要
目的:观察思密达治疗婴幼儿腹泻的临床疗效。方法:330例婴幼儿腹泻随机分成2组,治疗组180例,对照组150例。2组均给予抗感染、补液、纠正酸中毒和电解质紊乱,治疗组加用思密达,观察患儿腹泻次数、大便性状。结果:治疗组总有效率91.67%,对照组总有效率78%,两组疗效比较有显著差异。思密达治疗组未出现明显不良反应。结论:思密达是治疗婴幼儿腹泻安全有效的药物。
Objective: To observe the clinical efficacy of smectite in treatment of infant diarrhea. Methods: 330 patients with infant diarrhea were randomly divided into treatment group (n=180) and control group (n=150). Beside routine treatment in all patients, the treatment group was given smectite. The change of diarrhea and properties of excrements before and after treatment was observed. Results: The whole efficacy rate of treatment group was 91.67%. The whole efficacy rate of control group was 78%. It showed significant difference in treatment group and control group (P < 0.05). Conclusion: Smectite is an effective and safe agent for the treatment of infant diarrhea.
出处
《岭南急诊医学杂志》
2005年第2期115-116,共2页
Lingnan Journal of Emergency Medicine
